Long noncoding RNA DLEU1 aggravates osteosarcoma carcinogenesis via regulating the miR-671-5p/DDX5 axis

References

• Meyers PA, Gorlick R. Osteosarcoma. Pediatr Clin North Am. 1997;44:973–989.
   PubMed Web of Science ®Google Scholar
• Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009;136:629–641.
   PubMed Web of Science ®Google Scholar
• Li Z, Yu X, Shen J. Long non-coding RNAs: emerging players in osteosarcoma. Tumor Biol. 2016;37:2811–2816.
   PubMedGoogle Scholar
• Chen R, Wang G, Zheng Y, et al. Long non-coding RNAs in osteosarcoma. Oncotarget. 2017;8:20462–20475.
   PubMedGoogle Scholar
• Li JP, Liu LH, Li J, et al. Microarray expression profile of long noncoding RNAs in human osteosarcoma. Biochem Biophys Res Commun. 2013;433:200–206.
   PubMed Web of Science ®Google Scholar
• Li Y, Shi B, Dong F, et al. Long non-coding RNA DLEU1 promotes cell proliferation, invasion, and confers cisplatin resistance in bladder cancer by regulating the miR-99b/HS3ST3B1 axis. Front Genet. 2019;10:280–288.
   PubMed Web of Science ®Google Scholar
• Liu C, Tian X, Zhang J, et al. Long non-coding RNA DLEU1 promotes proliferation and invasion by interacting with miR-381 and enhancing HOXA13 expression in cervical cancer. Front Genet. 2018;9:629.
   PubMed Web of Science ®Google Scholar
• Nishiyama K, Maruyama R, Niinuma T, et al. Screening for long noncoding RNAs associated with oral squamous cell carcinoma reveals the potentially oncogenic actions of DLEU1. Cell Death Dis. 2018;9:826.
   PubMed Web of Science ®Google Scholar
• Zhang S, Guan Y, Liu X, et al. Long non-coding RNA DLEU1 exerts an oncogenic function in non-small cell lung cancer. Biomed Pharmacother. 2019;109:985–990.
   PubMed Web of Science ®Google Scholar
• Liu T, Han Z, Li H, et al. LncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3. Mol Cancer. 2018;17:118.
   PubMed Web of Science ®Google Scholar
• Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155–159.
   PubMed Web of Science ®Google Scholar
• Wang K, Chang H. Molecular mechanisms of long noncoding RNAs. Molecul Cell. 2011;43:904–914.
   PubMed Web of Science ®Google Scholar
• Fang Y, Fullwood MJ. Roles, functions, and mechanisms of long non-coding RNAs in cancer. Genom Proteom Bioinf. 2016;14:42–54.
   PubMed Web of Science ®Google Scholar
• Gao S, Cai Y, Zhang H, et al. Long noncoding RNA DLEU1 aggravates pancreatic ductal adenocarcinoma carcinogenesis via the miR-381/CXCR4 axis. J Cell Physiol. 2019;234:6746–6757.
   PubMed Web of Science ®Google Scholar
• Wang LL, Sun KX, Wu DD, et al. DLEU1 contributes to ovarian carcinoma tumourigenesis and development by interacting with miR-490-3p and altering CDK1 expression. J Cell Mol Med. 2017;21:3055–3065.
   PubMed Web of Science ®Google Scholar
• Malgulwar PB, Pathak P, Singh M, et al. Downregulation of SMARCB1/INI1 expression in pediatric chordomas correlates with upregulation of miR-671-5p and miR-193a-5p expressions. Brain Tumor Pathol. 2017;34:155–159.
   PubMed Web of Science ®Google Scholar
• Barbagallo D, Condorelli A, Ragusa M, et al. Dysregulated miR-671-5p/CDR1-AS/CDR1/VSNL1 axis is involved in glioblastoma multiforme. Oncotarget. 2016;7:4746–4759.
   PubMedGoogle Scholar
• Tan X, Fu Y, Chen L, et al. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer. Oncotarget. 2016;7:293–307.
   PubMedGoogle Scholar
• Qiu T, Wang K, Li X, et al. miR-671-5p inhibits gastric cancer cell proliferation and promotes cell apoptosis by targeting URGCP. Exp Ther Med. 2018;16:4753–4758.
   PubMed Web of Science ®Google Scholar
• Giraud G, Terrone S, Bourgeois CF. Functions of DEAD box RNA helicases DDX5 and DDX17 in chromatin organization and transcriptional regulation. BMB Rep. 2018;51:613–622.
   PubMed Web of Science ®Google Scholar
• Fuller-Pace FV. The DEAD box proteins DDX5 (p68) and DDX17 (p72): multi-tasking transcriptional regulators. Biochim Biophys Acta. 2013;1829:756–763.
   PubMed Web of Science ®Google Scholar
• Du C, Li DQ, Li N, et al. DDX5 promotes gastric cancer cell proliferation in vitro and in vivo through mTOR signaling pathway. Sci Rep. 2017;7:42876.
   PubMed Web of Science ®Google Scholar
• Wang Z, Luo Z, Zhou L, et al. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating beta-catenin signaling pathway. Cancer Sci. 2015;106:1303–1312.
   PubMed Web of Science ®Google Scholar
• Ma Z, Feng J, Guo Y, et al. Knockdown of DDX5 inhibits the proliferation and tumorigenesis in esophageal cancer. Oncol Res. 2017;25:887–895.
   PubMed Web of Science ®Google Scholar
• Mazurek A, Luo W, Krasnitz A, et al. DDX5 regulates DNA replication and is required for cell proliferation in a subset of breast cancer cells. Cancer Discov. 2012;2:812–825.
   PubMed Web of Science ®Google Scholar
• Nyamao RM, Wu J, Yu L, et al. Roles of DDX5 in the tumorigenesis, proliferation, differentiation, metastasis and pathway regulation of human malignancies. Biochim Biophys Acta Rev Cancer. 2019;1871:85–98.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang Q, Wang Q, et al. DEAD-Box helicase 5 interacts with transcription factor 12 and promotes the progression of osteosarcoma by stimulating cell cycle progression. Front Pharmacol. 2018;9:1558.
   PubMed Web of Science ®Google Scholar